PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2022Journal of Biomedical Research59 citationsOpen Access

Melanoma therapeutics: a literature review

View Full Paper
PDPavan Kumar DhanyamrajuTPTrupti Patel

Key Points

Key points are not available for this paper at this time.

Abstract

Melanoma is a relentless type of skin cancer which involves myriad signaling pathways which regulate many cellular processes. This makes melanoma difficult to treat, especially when identified late. At present, therapeutics include chemotherapy, surgical resection, biochemotherapy, immunotherapy, photodynamic and targeted approaches. These interventions are usually administered as either a single-drug or in combination, based on tumor location, stage, and patients' overall health condition. However, treatment efficacy generally decreases as patients develop treatment resistance. Genetic profiling of melanocytes and the discovery of novel molecular factors involved in the pathogenesis of melanoma have helped to identify new therapeutic targets. In this literature review, we examine several newly approved therapies, and briefly describe several therapies being assessed for melanoma. The goal is to provide a comprehensive overview of recent developments and to consider future directions in the field of melanoma.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Dhanyamraju et al. (2022) studied this question.

synapsesocial.com/papers/6a5e21a269f6c368eabc4a3fhttps://doi.org/10.7555/jbr.36.20210163
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients2006 · 75 citations
  2. 2IL-2, Regulatory T Cells, and Tolerance2004 · 558 citations
  3. 3Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics2020 · 322 citations
  4. 4Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas1989 · 2,087 citations
  5. 5Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes2018 · 660 citations